NCT05026593 2023-07-19A Study of IBI110 in Combination With Sintilimab and Chemotherapy in Patients With Untreated Extensive-Stage Small Cell Lung CancerInnovent Biologics (Suzhou) Co. Ltd.Phase 1 Completed60 enrolled